Catalyst Wire Dossier Catalyst Wire Dossier

COL-1620 Vaginal Progesterone Gel

progesterone vaginal gel · Merck KGaA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COL-1620 Vaginal Progesterone Gel, covering 2015-12-21 to 2015-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel [Phase 3]

See pricing